GAS_Vaccinology__Capturing_Global_Vaccine_Antigen_Diversity

This project consists of a two-phase action plan designed to validate the overall aims of the GAS vaccinology programme as well as generating publishable units from scientifically robust comparisons. Apart from vaccine antigen design, this programme of sequencing will support targeted analyses of specific disease associations and global transmission patterns of prominent sequence types- all ongoing sequencing based research foci that Sanger (Mark Davies) is currently analysing.